220 related articles for article (PubMed ID: 32824687)
21. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.
Ng PY; Cheng TS; Zhao H; Ye S; Sm Ang E; Khor EC; Feng HT; Xu J; Zheng MH; Pavlos NJ
J Bone Miner Res; 2013 Jan; 28(1):119-34. PubMed ID: 22887640
[TBL] [Abstract][Full Text] [Related]
22. Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption.
Dodds RA; James IE; Rieman D; Ahern R; Hwang SM; Connor JR; Thompson SD; Veber DF; Drake FH; Holmes S; Lark MW; Gowen M
J Bone Miner Res; 2001 Mar; 16(3):478-86. PubMed ID: 11277265
[TBL] [Abstract][Full Text] [Related]
23. The role of cathepsin K in normal bone resorption.
Troen BR
Drug News Perspect; 2004; 17(1):19-28. PubMed ID: 14993931
[TBL] [Abstract][Full Text] [Related]
24. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
25. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
[TBL] [Abstract][Full Text] [Related]
26. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
27. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
28. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
[TBL] [Abstract][Full Text] [Related]
29. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
30. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption.
Inui T; Ishibashi O; Inaoka T; Origane Y; Kumegawa M; Kokubo T; Yamamura T
J Biol Chem; 1997 Mar; 272(13):8109-12. PubMed ID: 9079619
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells.
Li Z; Li C; Zhou Y; Chen W; Luo G; Zhang Z; Wang H; Zhang Y; Xu D; Sheng P
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E355-66. PubMed ID: 26670486
[TBL] [Abstract][Full Text] [Related]
33. Osteoprotegerin influences the bone resorption activity of osteoclasts.
Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
[TBL] [Abstract][Full Text] [Related]
34. The Mechanism Switching the Osteoclast From Short to Long Duration Bone Resorption.
Delaisse JM; Søe K; Andersen TL; Rojek AM; Marcussen N
Front Cell Dev Biol; 2021; 9():644503. PubMed ID: 33859985
[TBL] [Abstract][Full Text] [Related]
35. Real-time analysis of osteoclast resorption and fusion dynamics in response to bone resorption inhibitors.
Panwar P; Olesen JB; Blum G; Delaisse JM; Søe K; Brömme D
Sci Rep; 2024 Mar; 14(1):7358. PubMed ID: 38548807
[TBL] [Abstract][Full Text] [Related]
36. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.
Saftig P; Hunziker E; Wehmeyer O; Jones S; Boyde A; Rommerskirch W; Moritz JD; Schu P; von Figura K
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13453-8. PubMed ID: 9811821
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts.
Cremasco V; Decker CE; Stumpo D; Blackshear PJ; Nakayama KI; Nakayama K; Lupu TS; Graham DB; Novack DV; Faccio R
J Bone Miner Res; 2012 Dec; 27(12):2452-63. PubMed ID: 22806935
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system.
Collin-Osdoby P; Li L; Rothe L; Anderson F; Kirsch D; Oursler MJ; Osdoby P
J Bone Miner Res; 1998 Jan; 13(1):67-78. PubMed ID: 9443792
[TBL] [Abstract][Full Text] [Related]
39. The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts.
Thirukonda GJ; Uehara S; Nakayama T; Yamashita T; Nakamura Y; Mizoguchi T; Takahashi N; Yagami K; Udagawa N; Kobayashi Y
J Bone Miner Metab; 2016 Jul; 34(4):395-405. PubMed ID: 26063501
[TBL] [Abstract][Full Text] [Related]
40. RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts.
Kim M; Park JH; Go M; Lee N; Seo J; Lee H; Kim D; Ha H; Kim T; Jeong MS; Kim S; Kim T; Kim HS; Kang D; Shim H; Lee SY
Bone Res; 2024 May; 12(1):29. PubMed ID: 38744829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
